A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Recent news on Tiotropium Bromide


Independence very much a virtue at Boehringer Ingelheim  -  Mar 28, 2007
Pharma Times (subscription),Once again the stellar performance came from Spiriva (tiotropium bromide) for chronic obstructive pulmonary disease, which brought in 1.38 billion euros,

Almirall share listing should attract a lot of attention  -  Mar 2, 2007
Pharma Times (subscription),Analysts believe that Almirall will soon be in a position to challenge Boehringer Ingelheim's blockbuster Spiriva (tiotropium bromide) for the number one

Boehringer sees alternative to Spiriva inhaler device  Sep 10, 2006
...following an observational study on a soft mist inhaler (SMI) that Boehringer Ingelheim plans to use with its blockbuster drug Spiriva (tiotropium bromide). ... -In-PharmaTechnologist.com

Boehringer-Ingelheim: Respimat aims to protect Spiriva's success  Sep 8, 2006
...effects. The Respimat is currently in development for BI's most important respiratory product Spiriva (tiotropium bromide). Importantly ... -Pharmaceutical Business Review

Research and Markets: Three of Boehringer Ingelheim's Current ...  Sep 5, 2006
...sector. Spiriva (tiotropium bromide) is a novel, once-daily, inhaled treatment for chronic obstructive pulmonary disease. Micardis ... -Genetic Engineering News

Research and Markets: The Chronic Obstructive Pulmonary Disorder ...  Jul 12, 2006
Recently released bronchodilators Advair (salmeterol/fluticasone) and Spiriva (tiotropium bromide) have improved the standard of care for COPD. ... -Business Wire



American Journal of Respiratory and Critical Care Medicine Vol 173 ...  Mar 28, 2006
...[Abstract/Free Full Text]. Gosens R, Bos IS, Zaagsma J, Meurs H. Protective effects of tiotropium bromide in the progression of airway smooth muscle remodeling. ... - AJRCCM (subscription)

GlaxoSmithKline's TORCH Study Shows Positive Results - Update  Mar 28, 2006
German-based Pharma company Boehringer Ingelheim is assessing the potential long-term impact of SPIRIVA HandiHaler or tiotropium bromide inhalation capsules ... - Trading Markets


This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional